Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Classification of bone tumors

F Bertoni1, P Bacchini

  • 1Rizzoli Orthopedic Institute and Malpighi Hospital, Pathologic Anatomy and Histology, Bologna, Italy.

European Journal of Radiology
|July 4, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A retrospective analysis of phase I and phase I/II investigator-initiated clinical trials conducted by the Swiss Group for Clinical Cancer Research (SAKK).

ESMO open·2025
Same author

A systematic review of contemporary phase I trials in patients with lymphoma.

Critical reviews in oncology/hematology·2022
Same author

Overcoming PARPi resistance: Preclinical and clinical evidence in ovarian cancer.

Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy·2021
Same author

Induction TPF followed by concomitant treatment versus concomitant treatment alone in locally advanced head and neck cancer. A phase II-III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same author

Emerging therapies provide new opportunities to reshape the multifaceted interactions between the immune system and lymphoma cells.

Leukemia·2016
Same author

Combination of the MEK inhibitor pimasertib with BTK or PI3K-delta inhibitors is active in preclinical models of aggressive lymphomas.

Annals of oncology : official journal of the European Society for Medical Oncology·2016
Same journal

Left atrial geometry in atrial Fibrillation: A comparison between electroanatomical mapping and computed tomography.

European journal of radiology·2026
Same journal

Enhancing pancreatic imaging in CT - prospective comparison of fixed versus individualized post-trigger delay in bolus tracking.

European journal of radiology·2026
Same journal

Ultrasound elastography of the liver and spleen in postoperative monitoring after abdominal surgery: A radiological perspective.

European journal of radiology·2026
Same journal

Co-clinical CT radiomics pipeline to establish candidate imaging biomarkers for colorectal cancer.

European journal of radiology·2026
Same journal

T2-MAP outperforms native T1-MAP for staging liver fibrosis independent of steatosis and iron overload: A dual-cohort causal validation study.

European journal of radiology·2026
Same journal

The added value of 3.0 T quantitative multivoxel proton <sup>1</sup>H-MR spectroscopy in the diagnostic work-up of breast lesions.

European journal of radiology·2026
See all related articles

This study details the classification of bone tumors, focusing on chondrogenic and osteogenic types. Understanding tumor cell features and matrix production is key for accurate diagnosis and treatment of bone cancers.

Area of Science:

  • Oncology
  • Pathology
  • Orthopedics

Background:

  • Bone tumor classification relies on reproducible cytologic features and cellular products.
  • Chondrogenic tumors, related to hyaline cartilage, are the second most common bone tumors.
  • Osteogenic tumors, including osteosarcomas, are the third most common group.

Purpose of the Study:

  • To outline the classification of chondrogenic and osteogenic bone tumors.
  • To describe the key histologic features differentiating various tumor types.
  • To explain the origins and classifications of chondrosarcomas and osteosarcomas.

Main Methods:

  • Review of histologic patterns and cytologic features of bone tumors.
  • Analysis of matrix production by tumor cells (cartilaginous or osteoid).

Related Experiment Videos

  • Classification based on cell type, matrix, grade, and origin (primary vs. secondary).

    • Main Results:

    • Chondrogenic tumors include exostoses, chondromas, chondroblastomas, chondromyxoid fibromas, and chondrosarcomas.
    • Osteogenic tumors are characterized by malignant cells producing osteoid matrix; osteosarcomas are the most frequent.
    • Chondrosarcomas can be primary or secondary, arising from benign lesions; osteosarcomas are graded by histologic features.

    Conclusions:

    • Accurate classification of bone tumors is essential for patient management.
    • Histologic features, particularly matrix production, are critical for differentiating benign and malignant bone tumors.
    • Understanding tumor origins and subtypes aids in prognosis and treatment strategies for bone cancers.